To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

The cost utility of pitol… - University of Gothenburg, Sweden Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Contact form








 


Note! If you want an answer on a question you must specify your email address




The cost utility of pitolisant as narcolepsy treatment

Journal article
Authors Kristian Bolin
P. A. Niska
Laura Pirhonen
Pontus Wasling
Published in Acta Neurologica Scandinavica
Volume 141
Issue 4
Pages 301-310
ISSN 0001-6314
Publication year 2020
Published at Centre for Health Economics
Institute of Neuroscience and Physiology, Department of Clinical Neuroscience
Department of Economics
Pages 301-310
Language en
Links dx.doi.org/10.1111/ane.13202
Keywords cost-effectiveness, narcolepsy, pitolisant, economic consequences, treatment options, sodium oxybate, double-blind, cataplexy, efficacy, placebo, health, Neurosciences & Neurology
Subject categories Clinical Medicine

Abstract

Objectives The cost-effectiveness of available pharmacological treatments for narcolepsy is largely

Page Manager: Webmaster|Last update: 9/11/2012
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?